When shock events impact the medicines supply chain, underlying vulnerabilities can cause it to break instead of bend, resulting in drug shortages. Such shocks can include an increase in demand due to emerging public health concerns.
Persistent and long-lasting shortages of childhood cancer treatments undermine the advancements in science that have helped to increase childhood cancer survival rates to 85 percent.
Since the start of the pandemic, the U.S. government has allocated over $34 billon to improve U.S. medicines supply chain resilience.
Consumers in the United States often have access to a lot of information about the products they use and consume. Many products include information about the country of origin.
